A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells <i>In Vitro</i>.

"Disclosure Statement T.B., P.A., E.A., L.J., S.L., and S.P. are co-founders and shareholders of Aprit AB (Swedish Biotech established with the University of Gothenburg's Ventures firm). Aprit AB is currently not active. E.A. and S.L. are co-founders and shareholders of Atley Solutions AB (Swedish Medtech established with the Chalmers University of Technology's Ventures firm). R.H. declares no competing financial interests."

"Funding Information This work was supported by the Swedish Research Council (2020–02204); the Swedish Cancer Society (190523Pj, 190523Fk); the Swedish Childhood Cancer Fund (PR2021-0097); the King Gustav V Jubilee Clinic Research Foundation; the Swedish Radiation Safety Authority; Gösta Miltons foundation; and grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-966276, ALFGBG-873621)."